Clinical Trial Update: Bendamustine in Acute Leukemia and MDS [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of bendamustine in acute leukemia and myelodysplastic syndromes was terminated with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Bendamustine (Bendamustine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2012-10-19